HK Stock Market Move | Zhenjiankang Medical (02697) rises over 13% to reach a new high. Domestic AI empowers early screening and treatment upgrades for lung cancer. The company continues to advance its layout in AI and digital healthcare.

Zhenjiankang Medical (02697) surged over 13%, hitting an intraday high of HKD 850, setting a new record since its listing. As of the time of this report, it rose by 13.29% to HKD 844, with a transaction volume of HKD 35.3578 million. In news, recently, the First Affiliated Hospital of Guangzhou University of Chinese Medicine introduced the Siasun Robot & Automation for AI-assisted thoracic surgery. Through precise AI localization of lung nodules, the upgrade shifts from traditional "blind screening" to "precise targeting," significantly enhancing the efficiency of early lung cancer diagnosis and treatment, providing patients with more accurate and minimally invasive treatment options. Industry insiders believe that as AI imaging recognition, 3D reconstruction, and Siasun Robot & Automation-assisted interventions continue to mature, the medical Siasun Robot & Automation industry is accelerating its entry into the commercialization phase, covering multiple high-value sectors including lung cancer, orthopedics, and neurosurgery, with substantial growth potential in the industry. It is reported that benefiting from the trend of medical intelligence upgrades, "the first stock of puncture surgery Siasun Robot & Automation" Zhenjiankang Medical is continually advancing its layout in artificial intelligence and digital healthcare. The company focuses on smart healthcare, AI-assisted diagnosis and treatment, and medical informatization, continuously enhancing its product system while actively promoting the application of AI technology in clinical settings of hospitals. With the continuous push for medical digitalization by the government and the acceleration of new technologies such as AI healthcare Siasun Robot & Automation and precision diagnosis and treatment, Zhenjiankang Medical is expected to benefit from improving industry conditions, further opening up long-term growth opportunities.